Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atenativ in Early and Severe Preeclampsia
NCT02278575Phase 4Withdrawn
- Sponsor
- Region Västra Götaland
- Start
- Jan 2016
- Primary completion
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of antithrombin III concentrate in preeclampsia, antithrombin III deficiency, sponsored by Region Västra Götaland. Planned start Jan 2016; status: withdrawn.
02
Drugs
antithrombin III concentrate
03
Conditions
preeclampsiaantithrombin III deficiency
Beyond the preview
Go deeper on NCT02278575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02278575.